Acquisition to enhance depth, breadth and value of services offered to pharmaceutical and biotech clients of both organizations
Prescient, a biopharma product and portfolio strategy firm, announced Tuesday the recent acquisition of Strategic North, a global commercial strategy consultancy that partners with a wide range of pharmaceutical companies to help them better understand how their customers make decisions in order to unlock the full potential of their brands.
Already have an account? Sign In
Already have an account? Sign In
*May exclude premium content